Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages E96-E100

  Chen, Xi ^a   Lu, Puhan ^a   He, Wentao ^a   Zhang, Jianhua ^a   Liu, Lei ^b   Yang, Yan ^a   Liu, Zhelong ^a   Xie, Junhui ^a   Shao, Shiying ^a   Du, Tingting ^a   Su, Xianghui ^a   Zhou, Xinrong ^a   Hu, Shuhong ^a   Yuan, Gang ^a   Zhang, Muxun ^a   Zhang, Hong ^a   Liu, Liegang ^a   Wang, Daowen ^b   Yu, Xuefeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Department of Internal Medicine Division of Cardiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETATROPHIN; PANCREAS HORMONE; UNCLASSIFIED DRUG; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE TOLERANCE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; AGED; BLOOD; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEPTIDE HORMONES; PREDIABETIC STATE;

EID: 84920597451     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2300     Document Type: Article

References (19)

1. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell. 2013;153:747-758.
2. Araujo TG, Oliveira AG, Saad MJ. Insulin-resistance-Associated compensatory mechanisms of pancreatic-cells: a current opinion. Front Endocrinol. 2013;4:146.
3. Kugelberg E. Diabetes: betatrophin-inducing-cell expansion to treat diabetes mellitus? Nat Rev Endocrinol. 2013;9:379.
4. Raghow R. Betatrophin: a liver-derived hormone for the pancreatic-cell proliferation. World J Diabetes. 2013;4:234-237.
5. Lickert H. Betatrophin fuels-cell proliferation: first step toward regenerative therapy? Cell Metab. 2013;18:5-6.
6. Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia. 2014;57:50-53.
7. Fenzl A, Itariu BK, Kosi L, et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014;57:1204-1208.
8. Fu Z, Berhane F, Fite A, Seyoum B , Abou-Samra AB, Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Scientific Rep. 2014;4:5013.
9. Espes D, Martinell M, Carlsson PO. Increased circulating beatatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol. 2014:323407.
10. Stewart AF. Betatrophin versus bitter-trophin and the elephant in the room: time for a new normal in-cell regeneration research. Diabetes. 2014;63:1198-1199.
11. Lu J, Bi Y, Wang T, et al. The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: resu lts of the REACTION study. Int J Cardiol. 2014;172:388-394.
12. American Diabetes Association. Standards of medical care in diabetes-2006 (Position Statement). Diabetes Care 2006;29(suppl 1): S4-S42.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and-cell function from fasting plasma glucose and insulin concen trations in man. Diabetologia. 1985;28:412-419.
14. Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev. 2003;61:397-412.
15. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012; 379:2279-2290.
16. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424:786-792.
17. Quagliarini F, Wang Y, Kozlitina J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci USA. 2012; 109:19751-19756.
18. Ren G, Kim JY, SmasCM.Identification of RIFL, a novel adipocyteenriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303:E334-E351.
19. Wang Y, Quagliarini F, Gusarova V, et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted trigly ceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA. 2013;110: 16109-16114.